发明名称 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
摘要 A process is provided for preparing an oral fast-melt composition of a selective cyclooxygenase-2 inhibitory drug comprising (a) a step of wet granulating the selective cyclooxygenase-2 inhibitory drug together with a binding agent selected from gums, polypeptides, natural and modified starches, cellulosic materials, alginic acid and salts thereof, polyethylene glycol, polyvinylpyrrolidone, polymethacrylates, silicate salts and bentonites, and (b) a step of blending with the drug a saccharide of low moldability, wherein the above steps (a) and (b) occur in any order or simultaneously to result in formation of granules. Optionally the process further comprises (c) a step of blending the granules with at least one of a lubricant, a sweetening agent and a flavoring agent to form a tableting blend, and (d) a step of compressing the tableting blend to form oral fast-melt tablets. Also provided is a composition prepared by such a process.
申请公布号 US2002049233(A1) 申请公布日期 2002.04.25
申请号 US20010932500 申请日期 2001.08.17
申请人 KARARLI TUGRUL T.;KONTNY MARK J.;LE TRANG T. 发明人 KARARLI TUGRUL T.;KONTNY MARK J.;LE TRANG T.
分类号 A61K9/20;A61K9/00;A61K9/16;A61K31/10;A61K31/122;A61K31/352;A61K31/353;A61K31/365;A61K31/415;A61K31/42;A61K31/444;A61K31/451;A61K31/485;A61K31/50;A61K31/635;A61K45/00;A61K47/02;A61K47/04;A61K47/10;A61K47/14;A61K47/18;A61K47/20;A61K47/26;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/42;A61P1/04;A61P1/16;A61P5/24;A61P9/00;A61P11/00;A61P11/06;A61P15/00;A61P17/00;A61P19/02;A61P19/10;A61P25/00;A61P25/28;A61P27/02;A61P27/06;A61P29/00;A61P29/02;A61P35/00;A61P43/00;(IPC1-7):A61K31/443;A61K31/18;A61K31/34;B27N3/00 主分类号 A61K9/20
代理机构 代理人
主权项
地址